These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 21419857

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
    Wang D, Strandgaard S, Iversen J, Wilcox CS.
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
    [Abstract] [Full Text] [Related]

  • 23. Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition.
    Zsuga J, Gesztelyi R, Török J, Kéki S, Bereczki D.
    Med Hypotheses; 2005 Feb; 65(6):1091-8. PubMed ID: 16125868
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
    Javadiyan S, Burdon KP, Whiting MJ, Abhary S, Straga T, Hewitt AW, Mills RA, Craig JE.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1923-7. PubMed ID: 22395885
    [Abstract] [Full Text] [Related]

  • 26. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.
    Perticone F, Sciacqua A, Maio R, Perticone M, Galiano Leone G, Bruni R, Di Cello S, Pascale A, Talarico G, Greco L, Andreozzi F, Sesti G.
    Int J Cardiol; 2010 Jul 23; 142(3):236-41. PubMed ID: 19168237
    [Abstract] [Full Text] [Related]

  • 27. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
    Jiang JL, Li Ns NS, Li YJ, Deng HW.
    Br J Pharmacol; 2002 Mar 23; 135(5):1175-82. PubMed ID: 11877324
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Xiong Y, Lei M, Fu S, Fu Y.
    Life Sci; 2005 May 27; 77(2):149-59. PubMed ID: 15862600
    [Abstract] [Full Text] [Related]

  • 30. Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I.
    Kasapkara ÇS, Tümer L, Biberoglu G, Kasapkara A, Hasanoğlu A.
    J Pediatr Endocrinol Metab; 2013 May 27; 26(5-6):427-31. PubMed ID: 23412857
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
    Tang WJ, Hu CP, Chen MF, Deng PY, Li YJ.
    Can J Physiol Pharmacol; 2006 Feb 27; 84(2):163-71. PubMed ID: 16900942
    [Abstract] [Full Text] [Related]

  • 33. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT, Selcuk H, Temizhan A, Maden O, Ulupinar H, Baysal E, Ozeke O, Sasmaz A.
    Coron Artery Dis; 2007 Nov 27; 18(7):545-51. PubMed ID: 17925608
    [Abstract] [Full Text] [Related]

  • 34. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.
    van der Zwan LP, Scheffer PG, Dekker JM, Stehouwer CD, Heine RJ, Teerlink T.
    Clin Sci (Lond); 2011 Jul 27; 121(2):71-8. PubMed ID: 21306304
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, Sutcu R, Yilmaz N.
    Ann Clin Lab Sci; 2006 Jul 27; 36(4):449-54. PubMed ID: 17127734
    [Abstract] [Full Text] [Related]

  • 37. The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine.
    Blackwell S.
    Ann Clin Biochem; 2010 Jan 27; 47(Pt 1):17-28. PubMed ID: 19940201
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A, Uzun H, Bavunoğlu I, Karter Y, Genç H, Vehid S.
    J Hum Hypertens; 2005 Aug 27; 19(8):629-33. PubMed ID: 15829997
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.